[Statins in chronic renal disease].Arq Bras Cardiol. 2005 Oct; 85 Suppl 5:45-9.AB
Abstract
Hypertriglyceridemia and low HDL-c are common features in patients with chronic renal failure. Cardiovascular mortality is substantially increased in the presence of chronic renal disease (10-20 times higher). There is evidence from clinical trials with statins suggesting their protective role in the progression of renal disease. In addition, reduced rates of non-fatal myocardial infarction and cardiac mortality were seen after renal transplant in patients receiving fluvastatin. However, a recent study with atorvastatin failed to demonstrate reduction in cardiovascular morbidity and mortality among diabetic patients on hemodialysis therapy. Ongoing trials will define the precise role of statins in this subset of patients.
MeSH
Pub Type(s)
English Abstract
Journal Article
Language
por
PubMed ID
16400399
Citation
Ferreira, Soraia R C., et al. "[Statins in Chronic Renal Disease]." Arquivos Brasileiros De Cardiologia, vol. 85 Suppl 5, 2005, pp. 45-9.
Ferreira SR, Rocha AM, Saraiva JF. [Statins in chronic renal disease]. Arq Bras Cardiol. 2005;85 Suppl 5:45-9.
Ferreira, S. R., Rocha, A. M., & Saraiva, J. F. (2005). [Statins in chronic renal disease]. Arquivos Brasileiros De Cardiologia, 85 Suppl 5, 45-9.
Ferreira SR, Rocha AM, Saraiva JF. [Statins in Chronic Renal Disease]. Arq Bras Cardiol. 2005;85 Suppl 5:45-9. PubMed PMID: 16400399.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Statins in chronic renal disease].
AU - Ferreira,Soraia R C,
AU - Rocha,Aloísio M,
AU - Saraiva,José Francisco K,
Y1 - 2006/01/02/
PY - 2006/1/10/pubmed
PY - 2006/5/12/medline
PY - 2006/1/10/entrez
SP - 45
EP - 9
JF - Arquivos brasileiros de cardiologia
JO - Arq Bras Cardiol
VL - 85 Suppl 5
N2 - Hypertriglyceridemia and low HDL-c are common features in patients with chronic renal failure. Cardiovascular mortality is substantially increased in the presence of chronic renal disease (10-20 times higher). There is evidence from clinical trials with statins suggesting their protective role in the progression of renal disease. In addition, reduced rates of non-fatal myocardial infarction and cardiac mortality were seen after renal transplant in patients receiving fluvastatin. However, a recent study with atorvastatin failed to demonstrate reduction in cardiovascular morbidity and mortality among diabetic patients on hemodialysis therapy. Ongoing trials will define the precise role of statins in this subset of patients.
SN - 0066-782X
UR - https://www.unboundmedicine.com/medline/citation/16400399/[Statins_in_chronic_renal_disease]_
DB - PRIME
DP - Unbound Medicine
ER -